HHS implements pricing targets based on OECD country GDP per capita

From Yahoo Finance: 2025-05-20 12:28:00

The US Department of Health and Human Services is implementing President Trump’s Executive Order to overhaul prescription drug pricing. Drugmakers must match lowest prices in comparable countries or face regulatory action. Prices are based on OECD country GDP per capita. Pharmaceutical manufacturers must meet specific targets identified by HHS to lower drug prices for American patients. US patients pay nearly three times more for prescription drugs than other developed nations. Pharma companies launched new US drugs at prices 35% higher in 2023. Drug price reforms are a key focus of the Trump administration.



Read more at Yahoo Finance: HHS sets “most favoured nation” pricing targets for drug makers